Mechanism of skin allograft enhancement across an H‐2 class I mutant difference. Evidence for involvement of veto cells

W. Martin Kast, E. van Twuyver, Rob J.D. Mooijaart, Marieke Verveld, Alfons G. A. Kamphuis, Cornelis J.M. Melief, Leo P. de Waal

European Journal of Immunology · 1988 · 23 citations · 15 references

Concepts

Abstract

Intravenous injection of spleen cells across mutant class I H-2 incompatibility results in a drastic donor-specific prolongation of skin allograft survival and a marked decrease in the donor-specific cytotoxic T lymphocyte precursor (CTLp) frequency. This immunosuppressive effect depends on the presence of radiosensitive T cells in the donor cell inoculum. It was excluded that a graft-vs.-host reaction was responsible for the observed effects. In mixing experiments, spleen cells from animals transfused with allogeneic lymphocytes could not suppress a normal CTL response against the alloantigen, despite an excess of putative recipient-derived spleen suppressor cells. The data are compatible with the idea that donor T cells function as veto cells which inactivate recipient CTLp directed against the alloantigen expressed by the veto cell.

References

15